Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Intimation Meeting To Be Held On 31-07-2020 To Consider And Approve Quarterly Financial Results And To Consider And Decide On Payment Of Interim Dividend, If Any, For 2020-21.
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Friday, July 31, 2020, to inter alia, consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter ended June 30, 2020, and to consider and decide on payment of Interim Dividend, if any, for the financial year 2020-21. Intimation of the above meeting of the Board of Directors is also being published in newspapers, as required under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.24-07-2020
